» Go to news main
Molly Appeal paves the way to precision cancer treatment
Posted by Melanie Jollymore on
November 24, 2017
in
News
2017 Molly Appeal lead researchers (left to right) Wenda Greer, Zhaolin Xu and Paola Marignani. (Group photos by Danny Abriel; additional photos courtesy Dalhousie Medical Research Foundation)
A group of Dalhousie Medical School researchers is spearheading a new initiative to develop personalized cancer treatments, with support from Dalhousie Medical Research Foundation’s 2017-18 Molly Appeal.
“Every person’s cancer is as unique as their fingerprints,” says Dr. Paola Marignani, an internationally known cancer researcher and professor in Dalhousie’s Department of Biochemistry & Molecular Biology who’s leading this year’s Molly Appeal research initiative.
Read more on Dal News.
Recent News
- New global study Highlights the Biological Roots of Anxiety
- Dalhousie and NCIME launch first‑of‑its‑kind program in Membertou First Nation
- A message from Wanda M. Costen, PhD, Provost and Vice President Academic
- Rhodes scholar Sierra Sparks returns home to study medicine
- President Kim Brooks, Dr. Pat Croskerry appointed to Order of Canada
- Dal’s Highly Cited Researchers reflect on influential global research alliances
- A New Bursary Supporting Black Medical Students at Dalhousie
- Dalhousie’s first physician assistant cohort steps into Nova Scotia’s healthcare system